Dr. Rachna Shroff dies at 47 after battle with adenocarcinoma
Dr. Rachna Shroff, an internationally respected gastrointestinal oncologist and researcher at the University of Arizona who dedicated her career to studying pancreatic and biliary tract cancers, died at the age of 47 after a battle with terminal adenocarcinoma, according to ndtv.com.
Key Clinical Takeaways:
- Dr. Rachna Shroff passed away at age 47 following a diagnosis of terminal adenocarcinoma.
- She served as chief of the Division of Hematology and Oncology and associate dean for clinical and translational research at the University of Arizona College of Medicine – Tucson.
- Her personal diagnosis began earlier in the year after she noticed a swollen lymph node, which was initially evaluated as a form of lymphoma before advanced adenocarcinoma was identified.
The Career and Leadership of Dr. Shroff
Dr. Shroff built a distinguished medical and academic career focused on treating complex and rare gastrointestinal malignancies. According to ndtv.com, she completed her undergraduate work at Brown University and received her medical degree from Thomas Jefferson University. Following her education, she finished a fellowship with the University of Texas MD Anderson Cancer Center in 2010. She remained at MD Anderson as an associate professor of GI medical oncology until 2018, when she moved to the University of Arizona in Tucson.
At the University of Arizona, Dr. Shroff held multiple high-profile academic and clinical positions. She served as the chief of the Division of Hematology and Oncology, associate director of clinical investigations at the University of Arizona Cancer Center, and a professor of medicine. She was also named the inaugural John F. and Valli S. Duval Endowed Professor for Gastrointestinal Oncology and took on the role of associate dean for clinical and translational research at the College of Medicine – Tucson. Throughout her career, she authored more than 80 research publications and led numerous clinical trials aimed at improving treatments for aggressive cancers.
The Diagnosis and Progression of the Illness
Initial medical evaluations suggested a possible form of lymphoma. However, subsequent diagnostic testing revealed that the condition was a far more advanced and aggressive disease—specifically, terminal adenocarcinoma, a type of cancer that originates in the glands lining internal organs. This development meant she was facing the exact category of malignancy she spent her career studying in her clinical practice and laboratory research.
Professional groups and colleagues, including the American Society of Clinical Oncology (ASCO), remembered her as a dedicated physician and a pioneer who worked tirelessly to improve life for cancer patients. She is survived by her husband, Dr. Puneet Shroff, a professor of medicine and associate director of the Banner Medical Group’s Allergy Clinic, and her two children, 17-year-old daughter Simran and 13-year-old son Sachin.
Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.